Suppr超能文献

基于大鼠肠吸收的中药药对柴胡-芍药主要成分相互作用研究。

Interaction of the main components from the traditional Chinese drug pair Chaihu-Shaoyao based on rat intestinal absorption.

机构信息

Key Laboratory of New Drug Delivery System of Chinese Material Medica, Jiangsu Province, Academy of Chinese Medicine, 100 Shizi Road, Nanjing 210028, China.

出版信息

Molecules. 2011 Nov 17;16(11):9600-10. doi: 10.3390/molecules16119600.

Abstract

The Chaihu-Shaoyao drug pair (Bupleuri Radix and Paeoniae Radix Alba) which is a traditional Chinese drug pair, has been widely used for anti-inflammatory purposes. Saikosaponin a (SSA), saikosaponin d (SSD) and paeoniflorin are identified as the main components in the pair. The present study focused on the interaction of the main components based on investigating their intestinal absorption using a four-site perfused rat intestinal model in order to clarify the mechanism of the compatibility of Chaihu-Shaoyao. The concentrations of SSA, SSD and paeoniflorin in the intestinal perfusate were determined by LC/MS or UPLC (Ultra Performance Liquid Chromatography) methods, followed by P*(eff) (effective permeability) and 10% ABS (the percent absorption of 10 cm of intestine) calculations. The results showed that all of the three main components displayed very low permeabilities (P*(eff) < 0.4), which implied their poor absorption in the rat intestine. The absorption levels of SSA and SSD were similar in intestine and higher in ileum than those in other intestinal regions in the decreasing order: colon, jejunum and duodenum. However, there is no significant difference in the absorption of paeoniflorin in the four segments (P < 0.05). The P*(eff) values of paeoniflorin exhibited an almost 2.11-fold or 1.90-fold increase in ileum when it was co-administrated with SSA and SSD, as well as 2.42-, 2.18-fold increase in colon, respectively, whereas the absorptions of SSA and SSD were not influenced by paeoniflorin. In conclusion, SSA and SSD could promote the absorption of paeoniflorin. To some extent this might explain the nature of the compatibility mechanisms of composite formulae in TCMs.

摘要

柴胡-白芍药对(柴胡和白芍)是一种传统的中药药对,已被广泛用于抗炎目的。柴胡皂苷 a(SSA)、柴胡皂苷 d(SSD)和芍药苷被确定为该对药的主要成分。本研究基于使用四部位大鼠肠灌流模型研究主要成分的相互作用,以阐明柴胡-白芍配伍的作用机制,重点关注主要成分的相互作用。采用 LC/MS 或 UPLC(超高效液相色谱)方法测定肠灌流液中 SSA、SSD 和芍药苷的浓度,然后计算 P*(eff)(有效渗透率)和 10%ABS(10cm 肠段吸收的百分比)。结果表明,所有三种主要成分的渗透性都非常低(P*(eff)<0.4),这意味着它们在大鼠肠道中的吸收较差。SSA 和 SSD 的吸收水平在肠道中相似,在回肠中高于其他肠段,顺序为:结肠、空肠和十二指肠。然而,芍药苷在四个肠段的吸收没有显著差异(P<0.05)。当与 SSA 和 SSD 共同给药时,芍药苷的 P*(eff)值在回肠中增加了近 2.11 倍或 1.90 倍,在结肠中分别增加了 2.42 倍和 2.18 倍,而 SSA 和 SSD 的吸收不受芍药苷的影响。综上所述,SSA 和 SSD 可以促进芍药苷的吸收。在某种程度上,这可以解释中药复方配伍机制的性质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f00c/6264397/dce9657434f0/molecules-16-09600-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验